The role of limited life expectancy in personalized treatment decisions: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England
This study examines the survival outcomes of elderly patients (aged 80+ years) diagnosed with BCC in England, revealing that nearly half die within 5 years of diagnosis. The findings highlight the potential overtreatment in this population, emphasizing the need for incorporating frailty and life expectancy assessments into personalized treatment decisions to avoid unnecessary surgical risks.
Authors
- James Powell (ORCID: https://orcid.org/0000-0001-7750-4651)
- Birgitta van Bodegraven (ORCID: https://orcid.org/0000-0002-8359-9017)
- Zoe Claire Venables (ORCID: https://orcid.org/0000-0002-9929-2693)
- Nicholas Johnson (ORCID: https://orcid.org/0000-0002-3702-5530)
- Opeoluwa Fariyike (ORCID: https://orcid.org/0009-0009-3712-7738)
- Kate Quirke (ORCID: https://orcid.org/0000-0002-7785-8967)
Institutions
- University of East Anglia (GB)
- Norfolk and Norwich University Hospital (GB)
- British Association of Dermatologists (GB)
- Wye Valley NHS Trust (GB)
- National Cancer Registration Service (GB)
- NHS England
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1093/bjd/ljaf135
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- British Association of Dermatologists